Madeleine Hinwood

Dr. Madeleine Hinwood is a Conjoint Lecturer in the School of Medicine and Public Health at the University of Newcastle and serves as an academic evaluator for the Pharmaceutical Benefits Advisory Committee. Her research employs causal inference methodology and evidence synthesis to translate preclinical findings to human populations, focusing on cognitive outcomes in neurological disorders like stroke and multiple sclerosis. She specializes in pharmacoepidemiology, stress-related disorders, and health technology assessment.

Her investigations examine how post-stroke medications and stress influence long-term cognitive outcomes, utilizing national registries and clinical datasets. Current projects include analyzing antiplatelet therapy effects on dementia risk after stroke and comparative effectiveness of multiple sclerosis treatments. Research integrates neuroimmunology with epidemiological methods to identify modifiable risk factors for cognitive decline.

She has secured over $7.4 million in research funding and contributes to health policy through pharmaceutical evaluations. Her work informs clinical guidelines on drug safety and cognitive outcomes.